CHRISTINA LAKE CANNABIS - Asset Resilience Ratio

Latest as of November 2025: 0.19%

CHRISTINA LAKE CANNABIS (CLB) has an Asset Resilience Ratio of 0.19% as of November 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€52.31K
≈ $61.16K USD Cash + Short-term Investments

Total Assets

€28.02 Million
≈ $32.76 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how CHRISTINA LAKE CANNABIS's Asset Resilience Ratio has changed over time. See how financially flexible is CHRISTINA LAKE CANNABIS to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down CHRISTINA LAKE CANNABIS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CHRISTINA LAKE CANNABIS market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €52.31K 0.19%
Total Liquid Assets €52.31K 0.19%

Asset Resilience Insights

  • Limited Liquidity: CHRISTINA LAKE CANNABIS maintains only 0.19% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

CHRISTINA LAKE CANNABIS Industry Peers by Asset Resilience Ratio

Compare CHRISTINA LAKE CANNABIS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
Drug Manufacturers - Specialty & Generic 0.76%
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
Drug Manufacturers - Specialty & Generic 10.89%
Akums Drugs and Pharmaceutical
NSE:AKUMS
Drug Manufacturers - Specialty & Generic 28.08%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Tibet Weixinkang Medicine Co Ltd
SHG:603676
Drug Manufacturers - Specialty & Generic 40.81%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%

Annual Asset Resilience Ratio for CHRISTINA LAKE CANNABIS (2021–2024)

The table below shows the annual Asset Resilience Ratio data for CHRISTINA LAKE CANNABIS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-11-30 0.21% €50.00K
≈ $58.46K
€23.37 Million
≈ $27.32 Million
--
2023-11-30 0.00% €0.00
≈ $0.00
€15.96 Million
≈ $18.66 Million
--
2022-11-30 0.15% €28.75K
≈ $33.61K
€18.79 Million
≈ $21.97 Million
+0.00pp
2021-11-30 0.15% €28.75K
≈ $33.61K
€19.04 Million
≈ $22.26 Million
--
pp = percentage points

About CHRISTINA LAKE CANNABIS

F:CLB Germany Drug Manufacturers - Specialty & Generic
Market Cap
$3.05 Million
€2.60 Million EUR
Market Cap Rank
#29460 Global
#2555 in Germany
Share Price
€0.01
Change (1 day)
+0.00%
52-Week Range
€0.01 - €0.04
All Time High
€0.70
About

Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christin… Read more